IDH1 and central nervous system cancer: Although the IDH1 mutation is not the core mechanism of 5-ALA fluorescence considering the discrepancy between 5-ALA fluorescence and IDH1 mutation prevalence in grade II or IV gliomas, we showed that the IDH1 mutation acts as a sensitizer when the cell is under the condition of altered 5-ALA metabolism.